4btw

From Proteopedia

(Difference between revisions)

Revision as of 17:07, 7 September 2022

Crystal structure of human vascular adhesion protein-1 in complex with pyridazinone inhibitors

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/4btw"

@@ Line 3: / Line 3: @@
 <StructureSection load='4btw' size='340' side='right'caption='[[4btw]], [[Resolution|resolution]] 2.80&Aring;' scene=''>
 == Structural highlights ==
-<table><tr><td colspan='2'>[[4btw]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4BTW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4BTW FirstGlance]. <br>
+<table><tr><td colspan='2'>[[4btw]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4BTW OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4BTW FirstGlance]. <br>
-</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CU:COPPER+(II)+ION'>CU</scene>, <scene name='pdbligand=JW7:5-(CYCLOHEXYLAMINO)-2-PHENYL-6-(1H-1,2,4-TRIAZOL-5-YL)-3(2H)-PYRIDAZINONE'>JW7</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
+</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CU:COPPER+(II)+ION'>CU</scene>, <scene name='pdbligand=JW7:5-(CYCLOHEXYLAMINO)-2-PHENYL-6-(1H-1,2,4-TRIAZOL-5-YL)-3(2H)-PYRIDAZINONE'>JW7</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=TPQ:5-(2-CARBOXY-2-AMINOETHYL)-2-HYDROXY-1,4-BENZOQUINONE'>TPQ</scene></td></tr>
-<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=TPQ:5-(2-CARBOXY-2-AMINOETHYL)-2-HYDROXY-1,4-BENZOQUINONE'>TPQ</scene></td></tr>
+<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4btw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4btw OCA], [https://pdbe.org/4btw PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4btw RCSB], [https://www.ebi.ac.uk/pdbsum/4btw PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4btw ProSAT]</span></td></tr>
-<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4btx|4btx]], [[4bty|4bty]]</td></tr>
-<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Primary-amine_oxidase Primary-amine oxidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.4.3.21 1.4.3.21] </span></td></tr>
-<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4btw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4btw OCA], [http://pdbe.org/4btw PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4btw RCSB], [http://www.ebi.ac.uk/pdbsum/4btw PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4btw ProSAT]</span></td></tr>
 </table>
 == Function ==
-[[http://www.uniprot.org/uniprot/AOC3_HUMAN AOC3_HUMAN]] Cell adhesion protein that participates in lymphocyte recirculation by mediating the binding of lymphocytes to peripheral lymph node vascular endothelial cells in an L-selectin-independent fashion. Has a monoamine oxidase activity. May play a role in adipogenesis.<ref>PMID:9653080</ref> <ref>PMID:17400359</ref> <ref>PMID:19588076</ref>
+[[https://www.uniprot.org/uniprot/AOC3_HUMAN AOC3_HUMAN]] Cell adhesion protein that participates in lymphocyte recirculation by mediating the binding of lymphocytes to peripheral lymph node vascular endothelial cells in an L-selectin-independent fashion. Has a monoamine oxidase activity. May play a role in adipogenesis.<ref>PMID:9653080</ref> <ref>PMID:17400359</ref> <ref>PMID:19588076</ref>
-<div style="background-color:#fffaf0;">
-== Publication Abstract from PubMed ==
-Vascular adhesion protein-1 (VAP-1) is a primary amine oxidase and a drug target for inflammatory and vascular diseases. Despite extensive attempts to develop potent, specific, and reversible inhibitors of its enzyme activity, the task has proven challenging. Here we report the synthesis, inhibitory activity, and molecular binding mode of novel pyridazinone inhibitors, which show specificity for VAP-1 over monoamine and diamine oxidases. The crystal structures of three inhibitor-VAP-1 complexes show that these compounds bind reversibly into a unique binding site in the active site channel. Although they are good inhibitors of human VAP-1, they do not inhibit rodent VAP-1 well. To investigate this further, we used homology modeling and structural comparison to identify amino acid differences, which explain the species-specific binding properties. Our results prove the potency and specificity of these new inhibitors, and the detailed characterization of their binding mode is of importance for further development of VAP-1 inhibitors.
-Novel Pyridazinone Inhibitors for Vascular Adhesion Protein-1 (VAP-1): Old Target-New Inhibition Mode.,Bligt-Linden E, Pihlavisto M, Szatmari I, Otwinowski Z, Smith DJ, Lazar L, Fulop F, Salminen TA J Med Chem. 2013 Dec 13. PMID:24304424<ref>PMID:24304424</ref>
-From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-</div>
-<div class="pdbe-citations 4btw" style="background-color:#fffaf0;"></div>
 ==See Also==
-*[[Copper Amine Oxidase|Copper Amine Oxidase]]
+*[[Copper amine oxidase 3D structures|Copper amine oxidase 3D structures]]
 == References ==
 <references/>
@@ Line 30: / Line 18: @@
 [[Category: Homo sapiens]]
 [[Category: Large Structures]]
-[[Category: Primary-amine oxidase]]
+[[Category: Bligt-Linden E]]
-[[Category: Bligt-Linden, E]]
+[[Category: Fulop F]]
-[[Category: Fulop, F]]
+[[Category: Lazar L]]
-[[Category: Lazar, L]]
+[[Category: Otwinowski Z]]
-[[Category: Otwinowski, Z]]
+[[Category: Pihlavisto M]]
-[[Category: Pihlavisto, M]]
+[[Category: Salminen TA]]
-[[Category: Salminen, T A]]
+[[Category: Smith DJ]]
-[[Category: Smith, D J]]
+[[Category: Szatmari I]]
-[[Category: Szatmari, I]]
-[[Category: Oxidoreductase]]

4btw

From Proteopedia

Revision as of 17:07, 7 September 2022

Crystal structure of human vascular adhesion protein-1 in complex with pyridazinone inhibitors

Structural highlights

Function

See Also

References

Contents

Proteopedia Page Contributors and Editors (what is this?)

Views

Personal tools

Navigation

Search

Toolbox